TUSC2 and non-small cell lung carcinoma: In the current study, we examined the role of TUSC2 in regulating PD-L1 expression in NSCLC and showed that TUSC2 can mediate PD-L1 downregulation potentially enhancing the efficacy of the antitumor immune response.